China hospitals may need official nod for major medical equipment

Lab work

China wants to give a thumbs-up or -down on the installation of major medical equipment in hospitals and related institutions and clinics, according to a draft rule from the State Council.

CRI Online said the proposed rule is aimed at halting overuse of the equipment to boost earnings at clinics and hospitals. The draft is open for comment until June 4.

Though the types of equipment were not specified in the report, high-end imaging equipment has received constant scrutiny as domestic firms in the space look to compete with firms like General Electric ($GE) and Siemens ($SI).

Conference

The 13th Annual Digital Pharma East

Digital Pharma East returns to the Pennsylvania Convention Center September 17–20, bringing together over 1000 attendees from biotech and pharma, to better understand how to present business plans, justify budget and innovation, and de-risk proposals getting shut down — essentially, understand how they can return to the office and become champions for their internal digital needs. Join us and save 15% on standard rates when you register with Discount Code DPE19Fierce.

According to the news site, the draft rule would have any buyers of major equipment first get approval from provincial health authorities.

Then, if the equipment is approved and installed, its use would be evaluated and regulated by the same authorities--with any breaches linked to improper use leading to possible suspensions in operations and fines.

- here's the story from CRI Online

Read more on

Suggested Articles

Hanmi loses Janssen obesity pact, while Yuhan signs NASH deal with Boehringer. GSK sells a Chinese site to Fosun as it opens facilities in Singapore.

Even as GlaxoSmithKline has opened its most advanced manufacturing site in Asia, it is selling an older plant in China to Fosun Pharma. 

GlaxoSmithKline has opened continuous manufacturing operations in Singapore that will make products faster, with less cost and less waste.